Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The efficiency of the complement system as an innate immune defense mechanism depends on a fine control that restricts its action to pathogens and prevents non-specific damage to host tissues. Genetic and functional analyses have shown that this critical control of complement activation may be impaired in atypical hemolytic uremic syndrome (aHUS) patients. Mutations in HF1, MCP or FI have been found in aHUS patients, but incomplete penetrance of the disease in individuals carrying these mutations is relatively frequent and no genetic defect has yet been found in a majority of aHUS patients. We report here the identification of a specific SNP haplotype block, spanning the MCP gene in the regulators of complement activation gene cluster, which is over-represented in aHUS patients and strongly associates with the severity of the disease. Linkage disequilibrium analyses suggest that this SNP haplotype also includes the CR1, DAF and C4BP genes. Initial studies identified two SNPs in the haplotype that influence the transcription activity of the MCP promoter in transient transfection experiments. Notably, the SNP haplotype block was found to be particularly frequent among patients who carry mutations in HF1, MCP or FI. These findings and the identification of aHUS patients carrying mutations in two complement regulatory genes provide an important insight into the etiology of aHUS. Together, they suggest that complement regulatory molecules act as a protein network and that multiple hits, involving plasma- and membrane-associated complement regulatory proteins, are necessary to impair protection to host tissues and to confer significant predisposition to aHUS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weir, B. S. (1997) · Biometrics · doi:10.2307/2533134 · Cited by 2,263
Nyholt, D. R. (2004) · The American Journal of Human Genetics · doi:10.1086/383251 · Cited by 1,699
Moake, J. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020528 · Cited by 1,221
Luciferase reporter gene vectors for analysis of promoters and enhancers.
Nordeen, S. K. (1988) · PubMed · Cited by 994
Hill, W. G. (1996) · Genetical Research · doi:10.1017/s0016672300034121 · Cited by 917
The human complement factor H: functional roles, genetic variations and disease associations
RODRIGUEZDECORDOBA, S., ESPARZAGORDILLO, J., GOICOECHEADEJORGE, E., LOPEZTRASCASA, M., & SANCHEZCORRAL, P. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.02.005 · Cited by 574
Self-citationGenetic studies into inherited and sporadic hemolytic uremic syndrome
Warwicker, P., Goodship, T. H. J., Donne, R. L., Pirson, Y., Nicholls, A., Ward, R. M., Turnpenny, P., & Goodship, J. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00824.x · Cited by 497
The Regulators of Complement Activation (RCA) Gene Cluster
Hourcade, D., Holers, V. M., & Atkinson, J. P. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60697-5 · Cited by 439
Richards, A., Kemp, E. J., Liszewski, M. K., Goodship, J. A., Lampe, A. K., Decorte, R., Müslümanogğlu, M. H., Kavukcu, S., Filler, G., Pirson, Y., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135497100 · Cited by 405
Manuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P. H., Remuzzi, G., & Zipfel, P. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16651 · Cited by 350
Cited by
Caprioli, J., Noris, M., Brioschi, S., Pianetti, G., Castelletti, F., Bettinaglio, P., Mele, C., Bresin, E., Cassis, L., Gamba, S., et al. (2006) · Blood · doi:10.1182/blood-2005-10-007252 · Cited by 732
Goodship, T. H. J., Cook, H. T., Fakhouri, F., Fervenza, F. C., Frémeaux-Bacchi, V., Kavanagh, D., Nester, C. M., Noris, M., Pickering, M. C., Rodríguez de Córdoba, S., et al. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.005 · Cited by 701
Atypical hemolytic uremic syndrome
Loirat, C., & Frémeaux-Bacchi, V. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-60 · Cited by 669
Noris, M., & Remuzzi, G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100861 · Cited by 635
Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts
Gehrs, K. M., Anderson, D. H., Johnson, L. V., & Hageman, G. S. (2006) · Annals of Medicine · doi:10.1080/07853890600946724 · Cited by 631
Servais, A., Noël, L.-H., Roumenina, L. T., Le Quintrec, M., Ngo, S., Dragon-Durey, M.-A., Macher, M.-A., Zuber, J., Karras, A., Provot, F., et al. (2012) · Kidney International · doi:10.1038/ki.2012.63 · Cited by 575
Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Kemp, E. J., Mayland, E., Winney, R. J., Duffield, J. S., Warwick, G., Richards, A., Ward, R., Goodship, J. A., & Goodship, T. H. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010103 · Cited by 475
de Jorge, E. G., Harris, C. L., Esparza-Gordillo, J., Carreras, L., Arranz, E. A., Garrido, C. A., López-Trascasa, M., Sánchez-Corral, P., Morgan, B. P., & de Córdoba, S. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603420103 · Cited by 447
Self-citationSTEC-HUS, atypical HUS and TTP are all diseases of complement activation
Noris, M., Mescia, F., & Remuzzi, G. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.195 · Cited by 383
Moore, I., Strain, L., Pappworth, I., Kavanagh, D., Barlow, P. N., Herbert, A. P., Schmidt, C. Q., Staniforth, S. J., Holmes, L. V., Ward, R., et al. (2010) · Blood · doi:10.1182/blood-2009-05-221549 · Cited by 357
Bresin, E., Rurali, E., Caprioli, J., Sanchez-Corral, P., Fremeaux-Bacchi, V., Rodriguez de Cordoba, S., Pinto, S., Goodship, T. H. J., Alberti, M., Ribes, D., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012090884 · Cited by 352
Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Goodship, T. H., & Richards, A. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.003 · Cited by 348
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy
Noris, M., Galbusera, M., Gastoldi, S., Macor, P., Banterla, F., Bresin, E., Tripodo, C., Bettoni, S., Donadelli, R., Valoti, E., et al. (2014) · Blood · doi:10.1182/blood-2014-02-558296 · Cited by 341
Age‐related Macular Degeneration (AMD)
(2008) · Encyclopedia of Molecular Pharmacology · doi:10.1007/978-3-540-38918-7_5059 · Cited by 314
Atypical aHUS: State of the art
Nester, C. M., Barbour, T., de Cordoba, S. R., Dragon-Durey, M. A., Fremeaux-Bacchi, V., Goodship, T. H. J., Kavanagh, D., Noris, M., Pickering, M., Sanchez-Corral, P., et al. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.03.246 · Cited by 299
De Córdoba, S. R., & De Jorge, E. G. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03552.x · Cited by 287
Pickering, M. C., de Jorge, E. G., Martinez-Barricarte, R., Recalde, S., Garcia-Layana, A., Rose, K. L., Moss, J., Walport, M. J., Cook, H. T., de Córdoba, S. R., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070301 · Cited by 278
Besbas, N., Karpman, D., Landau, D., Loirat, C., Proesmans, W., Remuzzi, G., Rizzoni, G., Taylor, C. M., Van de Kar, N., & Zimmerhackl, L. B. (2006) · Kidney International · doi:10.1038/sj.ki.5001581 · Cited by 277
Taylor, C. M., Machin, S., Wigmore, S. J., Goodship, T. H. J., & on behalf of a working party from the Renal Association, T. B. C. F. S. I. H. A. T. B. T. S. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07916.x · Cited by 277
Campistol, J. M., Arias, M., Ariceta, G., Blasco, M., Espinosa, L., Espinosa, M., Grinyó, J. M., Macía, M., Mendizábal, S., Praga, M., et al. (2015) · Nefrología · doi:10.1016/j.nefro.2015.07.005 · Cited by 272
Diseases of complement dysregulation-an overview
Wong, E. K. S., & Kavanagh, D. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-017-0663-8 · Cited by 115
Gavriilaki, E., Anagnostopoulos, A., & Mastellos, D. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00337 · Cited by 106
Ram, S., Shaughnessy, J., DeOliveira, R. B., Lewis, L. A., Gulati, S., & Rice, P. A. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.05.016 · Cited by 35
Metadata
- Authors
- Esparza-Gordillo, J., Jorge, E. G. D., Buil, A., Berges, L. C., López-Trascasa, M., Sánchez-Corral, P., & Córdoba, S. R. D.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01-20
- Volume
- 14
- Issue
- 5
- Pages
- 703-712
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2135056130
- Cited by
- 281
- References
- 29
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.